Intelligent Bio Solutions Inc. (INBS) stock
INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3061% below fair value
$1.76−0.17 (-8.81%)
Close on Nov 13, 2026Market cap $5.33MP/E –Yield –
Intelligent Bio Solutions ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Intelligent Bio Solutions's ebitda for the twelve months ending Sep 30, 2026 was -$11.08M. For fiscal 2026 it was -$11.44M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$11.44M | – |
| FY2025 | Jun 30, 2025 | -$9.47M | – |
| FY2024 | Jun 30, 2024 | -$9.31M | – |
| FY2023 | Jun 30, 2023 | -$11.78M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | -$2.39M | – |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$3.68M | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$2.66M | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$2.35M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -$2.70M | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$2.81M | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$2.26M | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$1.96M | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$2.48M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$2.58M | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$2.63M | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$1.70M | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$2.28M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -$2.59M | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$6.14M | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$1.73M | – |
See a number that looks wrong?